French biotech firm One Biosciences, which uses artificial intelligence to develop personalized cancer treatments, is setting ...

Several of pharma’s top leaders scored large pay bumps last year, including two new chiefs who joined the “$30 million club.” ...

Eli Lilly, the maker of the popular GLP-1 injectable Mounjaro, has invested heavily in Houston as a biotechnology hub.

Prime Medicine has hired Svetlana Makhni as the biotechnology company's new chief financial officer. Prime on Thursday said Makhni, 42 years old, previously served as finance chief of clinical-stage ...

For decades, America has led the global biotech industry – thanks, in part, to state-level policies that encourage research and manufacturing investments.

After receiving a drug rejection from the FDA, Woburn-based Replimune Group (Nasdaq: REPL) has informed the state that it ...

LifeSciencesNY, a trade group based in Central New York, urges state legislators to fund this effort in the upcoming state ...

NCBioImpact, a public/private partnership created to bring together key resources to produce world-class biopharma ...

Dozens of Massachusetts workers are about to lose their jobs after the FDA rejected a promising cancer drug — for the second ...

New Jersey's Johnson & Johnson grew from one ambitious pharmacist to a $94 billion pharmaceutical and medical device giant.

Amidst rising layoffs in key biotech hubs, global demand for specialized life sciences talent is driving a more borderless, ...

The first three months of 2026 saw 14 companies announce cuts. That's a ramp-up from the prior quarter, which saw 476 workers ...